Impact of motivational pharmacotherapy on treatment retention among depressed latinos

Psychiatry (New York)

Volumn 76, Issue 3, 2013, Pages 210-222

  Lewis Fernández, Roberto ^a   Balán, Iván C ^a   Patel, Sapana R ^a   Sánchez Lacay, J Arturo ^a   Blanco, Carlos ^a   Schneier, Franklin ^a   Alfonso, César ^b   Gorritz, Magdaliz ^a   Schmidt, Andrew ^a   Jiang, Huiping ^a   Moyers, Theresa B ^c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CULTURAL FACTOR; DOCTOR PATIENT RELATION; ETHNOLOGY; FEMALE; HEALTH CARE DISPARITY; HISPANIC; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR DEPRESSION; MALE; METHODOLOGY; MINORITY GROUP; MOTIVATIONAL INTERVIEWING; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PILOT STUDY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; STATISTICS; TIME; UNITED STATES; DEPRESSIVE DISORDER, MAJOR; PROCEDURES; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ACCULTURATION; ADULT; ANTIDEPRESSIVE AGENTS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MINORITY GROUPS; MOTIVATIONAL INTERVIEWING; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; TIME FACTORS; UNITED STATES;

EID: 84895836808     PISSN: 00332747     EISSN: 1943281X     Source Type: Journal    
DOI: 10.1521/psyc.2013.76.3.210     Document Type: Article

References (53)

1. Alonso, M., Val, E., & Rapaport, M. H. (1997). An open-label study of SSRI treatment in depressed Hispanic and non-Hispanic women. Journal of Clinical Psychiatry, 58, 31.
2. Arnow, B. A., Blasey, C., Manber, R., Constantino, M. J., Markowitz, J. C., Klein, D. N., Rush, A. J. (2007). Dropouts versus completers among chronically depressed outpatients. Journal of Affective Disorders, 97, 197–202.
3. Balan, I., Moyers, T., & Lewis-Fernandez, R. (2013). Motivational pharmacotherapy: Combining motivational interviewing and antidepressant therapy to improve treatment adherence. Psychiatry, 76(3), 203–209.
4. Blanco, C., Olfson, M., Goodwin, R. D., Ogburn, E., Liebowitz, M. R., Nunes, E. V., & Hasin, D. S. Generalizability of clinical trial results for major depression to community samples. Journal of Clinical Psychiatry, 69, 1276–1280.
5. Borowsky, S. J., Rubenstein, L. V., Meredith, L. S., Camp, P., Jackson-Triche, M., & Wells, K. B. Who is at risk of nondetection of mental health problems in primary care? Journal of General Internal Medicine, 15, 381–388.
6. Bull, S. A., Hu, X. H., Hunkeler, E. M., Lee, J. Y., Ming, E. E., Markson, L. E., & Fireman, B. (2002). Discontinuation of use and switching of antidepressants: Influence of patient-physician communication. Journal of the American Medical Association, 288, 1403–1409.
7. Cabassa, L. J., Lester, R., & Zayas, L. H. (2007). “It’s like being in a labyrinth”: Hispanic immigrants’ perceptions of depression and attitudes toward treatments. Journal of Immigrant Health, 9, 1–16.
8. Carroll, K. M., & Onken, L. S. (2005). Behavioral therapies for drug abuse. American Journal of Psychiatry. 162, 1452–1460.
9. Cooper-Patrick, L., Gallo, J. J., Gonzales, J. J., Vu, H. T., Powe, N. R., Nelson, C., & Ford, D. E. (1999). Race, gender, and partnership in the patient-physician relationship. Journal of the American Medical Association, 282, 583–589.
10. Cortés, D. E., Mulvaney-Day, N., Fortuna, L., Reinfeld, S., & Alegria, M. (2009). Patient-provider communication: Understanding the role of patient activation for Latinos in mental health treatment. Health Education and Behavior, 36, 138–154.
11. Dwight-Johnson, M., Unutzer, J., Sherbourne, Tang, L. & Wells, K. B. (2001). Can quality improvement programs for depression in primary care address patient preferences for treatment? Medical Care, 39, 934–944.
12. Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (1993). Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure. Psycho-pharm Bulletin, 29, 321–326.
13. Escobar, J. I., & Tuason, V. B. (1980). Antidepressant agents: A cross-cultural study. Psychopharm Bulletin, 16, 49–52.
14. Field, C. A., Caetano, R., Harris, T. R., Frankowski, R., & Roudsari, B. (2009). Ethnic differences in drinking outcomes following a brief alcohol intervention in the trauma care setting. Addiction, 105, 62–73.
15. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1998). Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID I/P, Version 2.0 9/98 revision). New York: Biometrics Research Department, New York State Psychiatric Institute.
16. Givens, J. L., Houston, T. K., Van Voorhees, B. W., Ford, D. E., & Cooper, L. A. (2007). Ethnicity and preferences for depression treatment. General Hospital Psychiatry, 29, 182–191.
17. Gonzalez, H. M., Tarraf, W., West, B. T., Croghan, T. W., Bowen, M. E., Cao, Z., & Alegria, A. Antidepressant use in a nationally representative sample of community-dwelling US Latinos with and without depressive and anxiety disorders. Depression and Anxiety, 26, 674–681.
18. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62
19. Harman, J. S., Edlund, M. J., & Fortney, J. C. (2004). Disparities in the adequacy of depression treatment in the United States. Psychiatric Services, 55, 1379–1385.
20. Hettema, J., Steele, J., & Miller, W. R. (2005). Motivational interviewing. Annual Review of Clinical Psychology, 1, 91–111
21. Hodgkin, D., Volpe-Vartanian, J., & Alegria, M. (2007). Discontinuation of antidepressant medication among Latinos in the USA. Journal of Behavioral Health Services Research, 34, 329–342.
22. Interian, A., Ang, A., Gara, M. A., Link, B. G., Rodriguez, M. A., & Vega, W. A. (2010). Stigma and depression treatment utilization among Latinos: Utility of four stigma measures. Psychiatric Services, 61, 373–379.
23. Interian, A., Lewis-Fernandez, R., Gara, M. A., & Escobar, J. I. (2013). A randomized-controlled trial of an intervention to improve antidepressant adherence among Latinos with depression. Depression and Anxiety. Advance online publication. doi: 10.1002/da.22052
24. Interian, A, Martinez, I, Iglesias Rios, L, Krejci, J, & Guarnaccia, P. J. (2010). Adaptation of a motivational interviewing intervention to improve antidepressant adherence among Latinos. Cultural Diversity and Ethnic Minority Psychology, 16, 215–225.
25. Lagomasino, I. T., Zatzick, D. F., & Chambers, D. Efficiency in mental health practice and research. General Hospital Psychiatry, 32, 477–483.
26. Lanouette, N. M., Folsom, D. P., Sciolla, A., & Jeste, D. V. (2009). Psychotropic medication nonadherence among United States Latinos: A comprehensive literature review. Psychiatric Services, 60, 157–174.
27. Lewis-Fernandez, R. (2003). Role of cultural expectations of treatment in adherence research. Presentation at the NIMH Training Conference. Beyond the Clinic Walls: Expanding Mental Health, Drug and Alcohol Services Research Outside the Specialty Care System, Rockville, MD.
28. Lewis-Fernandez, R., Das, A. K., Alfonso, C., Weissman, M. M., & Olfson, M. (2005). Depression in US Hispanics: Diagnostic and management considerations in family practice. Journal of the American Board of Family Practice, 18, 282–296.
29. Marin, G. & Gamba, R. J. (1996). A new measurement of acculturation for Hispanics: The Bidimensional Acculturation Scale for Hispanics (BAS). Hispanic Journal of Behavioral Sciences, 18, 297–316.
30. Martinez-Pincay, I. E. & Guarnaccia, P. J. (2007). “It’s like going through an earthquake”: Anthropological perspectives on depression among Latino immigrants. Journal of Immigrant and Minority Health, 9, 17–28.
31. Mechanic, D., McAlpine, D., & Rosenthal, M. Are patients’ office visits with physicians getting shorter? New England Journal of Medicine, 344, 198–204.
32. Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change (2nd ed.). New York: Guilford.
33. Miller, W. R., & Rollnick, S. (2009). Ten things that motivational interviewing is not. Behavioral and Cognitive Psychotherapy, 37(2), 129–140.
34. Miranda, J., & Cooper, L. A. (2004). Disparities in care for depression among primary care patients. Journal of General Internal Medicine, 19, 120–126.
35. Miranda, J., Duan, N., Sherbourne, C., Shoenbaum, M., Lagomasino, I., Jackson-Triche, M., & Wells, K. B. (2003). Improving care for minorities: Can quality improvement interventions improve care and outcomes for depressed minorities? Results of a randomized, controlled trial. Health Services Research, 38, 613–630.
36. Moyers, T. B., Martin, T., Manuel, J. K., Hendrickson, S. M. L., & Miller, W.E. (2005). Assessing competence in the use of motivational interviewing. Journal of Substance Abuse Treatment, 28, 19–26.
37. Moyers, T. B., Martin, T., Houck, J. M., Christopher, P. J., & Tonigan, J. S. (2009). From insession behaviors to drinking outcomes: A causal chain for motivational interviewing. Journal of Consulting and Clinical Psychology, 77, 1113–1124.
38. Moyers, T. B., Martin, T., Manuel, J. K., Miller, W. R., & Ernst, D. (2003). The Motivational Interviewing Treatment Integrity (MITI) Coding Manual. Albuquerque: University of New Mexico Center on Alcoholism, Substance Abuse and Addictions (CASAA).
39. Olfson, M., Cherry, D. K., & Lewis-Fernandez, R. (2009). Racial differences in visit duration of outpatient psychiatric visits. Archives of General Psychiatry, 66, 214–221.
40. Olfson, M., Marcus, S. C., & Pincus, H. A. (1999). Trends in office-based psychiatric practice. American Journal of Psychiatry, 156, 451–457.
41. Olfson, M., Marcus, S. C., Tedeschi, M., & Wan, G. J. (2006). Continuity of antidepressant treatment for adults with depression in the United States. American Journal of Psychiatry, 163, 101–108.
42. Robbins, M., Liddle, H., Turner, C. W., Dakof, G. A., Alexander, J. F., & Kogan, S. M. (2006). Adolescent and parent therapeutic alliances as predictors of dropout in multidimensional family therapy. Journal of Family Psychology, 20, 108–116.
43. Rubak, S., Sandboek, A., Lauritzen, T., & Christensen, B. (2005). Motivational interviewing: A systematic review and meta-analysis. British Journal of General Practice, 55, 305–312.
44. Sanchez-Lacay, J. A., Lewis-Fernandez, R., Goetz, Blanco, C., Salman, E., Davies, S., & Liebowitz, M. (2001). Open trial of nefazodone among Hispanics with major depression: Efficacy, tolerability, and adherence issues. Depression and Anxiety, 13, 118–124.
45. Schraufnagel, T. J., Wagner, A. W., Miranda, J., & Roy-Byrne, P. (2006). Treating minority patients with depression and anxiety: What does the evidence tell us? General Hospital Psychiatry, 28, 27–36.
46. Sheehan, D. V., Harnett-Sheehan, K., & Raj, A. B. (1996). The measurement of disability. International Clinical Psychopharmacology, 11, 89–95.
47. Sleath, B., Rubin, R. H., & Huston, S. A. (2003). Hispanic ethnicity, physician-patient communication, and antidepressant adherence. Comprehensive Psychiatry, 44, 198–204.
48. Sleath, B., Rubin, R. H., & Wurst, K. (2003). The influence of Hispanic ethnicity on patients’ expression of complaints about and problems with adherence to antidepressant therapy. Clinical Therapeutics, 25, 1739–1749.
49. Wagner, G. J., Maguen, S., & Rabkin, J. G. (1998). Ethnic differences in response to fluoxetine in a controlled trial with depressed HIV-positive patients. Psychiatric Services, 49, 239–240.
50. Warden, D., Trivedi, M. H., Wisniewksi, S. R., Davis, L., Nierenberg, A. A., Gaynes, B. N., … Rush, A. J. (2007). Predictors of attrition during initial (citalopram) treatment for depression: A STAR*D report. American Journal of Psychiatry, 164, 1189–1197.
51. Warden, D., Rush, A. J., Wisniewski, S. R., Lesser, I. M., Kornstein, S. G., Balasubramani, G. K., … Trivedi, M. H. (2009). What predicts attrition in second step medication treatments for depression? A STAR*D report. International Journal of Neuropsychopharmacology, 12, 459–473.
52. Young, A. S., Klap, R., Sherbourne, C. D., & Wells, K. B. (2001). The quality of care for depressive and anxiety disorders in the United States. Archives of General Psychiatry, 58, 55–61.
53. Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002). Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159, 1653–1664.